The California Department of Public Health (CDPH) has issued an All Facilities Letter (AFL) regarding the voluntary recall of all unexpired lots of sterile products dispensed nationwide by Abrams Royal Pharmacy due to concerns of lack of sterility assurance. This recall was issued after a single report of an adverse outcome involving a patient in California who received a compounded medication from the pharmacy. Healthcare facilities, physicians, and patients who have received sterile products from Abrams Royal Pharmacy between June 17, 2013, and December 17, 2013, are advised to check their medications and stop using any recalled products. The pharmacy is notifying its customers and arranging for the return of all recalled medication. Healthcare professionals and patients are encouraged to report any serious problems or side effects related to the use of these products to their local health department and the FDA's MedWatch Adverse Event Reporting Program.

Summaries are generataed using AI. Check important information.